Lead Product(s) : AqubotulinumtoxinA,Inapplicable
Therapeutic Area : Dermatology
Study Phase : IND Enabling
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Dermatox (botulinum Toxin Type A-aqu) is a neuromodulator with a 900 kDa protein complex derived from neurotoxins produced by Clostridium botulinum. It is being investigated for the improvement of skin quality and reduction of fine lines for face and nec...
Product Name : Dermatox
Product Type : Protein
Upfront Cash : Inapplicable
April 28, 2023
Lead Product(s) : AqubotulinumtoxinA,Inapplicable
Therapeutic Area : Dermatology
Highest Development Status : IND Enabling
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : AqubotulinumtoxinA,Inapplicable
Therapeutic Area : Dermatology
Study Phase : IND Enabling
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Aquavit Files Two IND's For Its Botulinum Toxin With FDA
Details : DTX-023 (botulinum toxin type A) is a neuromodulator with a 900 kDa protein complex derived from neurotoxins produced by Clostridium botulinum. It is being investigated for primary axillary hyperhidrosis and palmar hyperhidrosis.
Product Name : Dermatox
Product Type : Protein
Upfront Cash : Inapplicable
March 17, 2023
Lead Product(s) : AqubotulinumtoxinA,Inapplicable
Therapeutic Area : Dermatology
Highest Development Status : IND Enabling
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : AqubotulinumtoxinA,Inapplicable
Therapeutic Area : Dermatology
Study Phase : IND Enabling
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Aquavit Files IND with FDA for DTX-021, a New Botulinum Toxin
Details : Dermatox (DTX-021) is a botulinum toxin type A drug, highly purified and clinically tested injectable neuromodulator with a 900 kDa protein complex derived from neurotoxins produced by Clostridium botulinum.
Product Name : Dermatox
Product Type : Protein
Upfront Cash : Inapplicable
March 24, 2022
Lead Product(s) : AqubotulinumtoxinA,Inapplicable
Therapeutic Area : Dermatology
Highest Development Status : IND Enabling
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable